Marijuana Stock Investing Is a Marathon, Not a Sprint

If you’re investing in Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) or The Flowr Corp. (TSXV:FLWR), it’s a slow burn. The pot stocks are similarly situated with the internet stocks that survived the dot-com bubble. The massive gains would come in due time.

| More on:
Modern buildings in business district

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Do you see similarities between the dot.com bubble and the booming cannabis industry? Both periods had spectacular beginnings. The most striking resemblance is in the rapid price surges and declines. In 1999 to 2000, investors lost millions, while many internet companies folded up.

Some internet companies, such as Amazon.com and eBay were able to survive, and both are doing well today. If the same thing is happening in the cannabis universe, it’s safe to say that investing in pot stocks is also a marathon.

It’s not a sprint if you’re thinking of investing in Canopy Growth (TSX:WEED)(NYSE:CGC) or Flowr (TSXV:FLWR). You can’t be sure whether the top-tier pot stock and the small-cap upstart can survive the burst of the marijuana bubble.

The same risks

At the height of the dot-com frenzy, people buy on rumours and sell on news. In the cannabis sector, stock price movements are news-driven. As the internet was a new technology then, there was so much hype over internet stocks. That same hype is occurring today, but this time, pot stocks are in the limelight.

Many people didn’t get their money back from tech stocks that went bust, which should serve as a valuable lesson to would-be cannabis investors. You have to be extra careful when picking pot stocks, as not all of them are winning stocks, and your holdings might be worthless in the end.

Big and small

Let’s look at Canopy Growth and Flowr. The pot stocks belong to the opposite ends of the spectrum — the most significant cannabis producer and a small industry fry. Which of the two is the better long-term investment?

Canopy Growth has a market capitalization of $10.83 billion, while Flowr’s is barely 3% of the undisputed market leader. Canopy is the hottest pot stock before and immediately after the legalization of adult-use marijuana. Alcohol beverage giant Constellation Brands came with $4 billion to partner with Canopy.

WEED was doing okay at the start of 2019. But after two disappointing quarterly reports, the stock crashed to dash all hopes of earning from the stock soon. Still, Canopy Growth is making up for it in terms of sales growth. The company will be in the red until 2021.

Flowr is a specialty grower whose goals are not as ambitious as Canopy Growth. Its focus is on premium and ultra-premium dried flower and derivatives. These high-margin products will boost sales growth by 356% in 2020. Flowr will soon have broader access to global investors when it begins trading on the NASDAQ.

Similar to the dot-com survivors

Amazon was among the biggest losers when the dot-com bubble burst. But the company emerged several years later as the e-commerce behemoth.

I believe Canopy Growth has the makings of Amazon. In about three to five years, the premier cannabis company will cement its industry-leading position.

Specialty retailer eBay did not suffer as much during the dot-com bubble, as its products and online auctions grew in popularity. Flowr could be following in eBay’s footsteps.

The company prioritizes quality over quantity. Its specialty products are high-priced, which would likely mean sustainable operating margins in the long run.

Canopy Growth and Flowr will survive the cannabis bubble. But remember, you’re investing for the long haul, not short-term gains.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

John Mackey, CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Fool contributor Christopher Liew has no position in any of the stocks mentioned. David Gardner owns shares of Amazon. The Motley Fool owns shares of Amazon and has the following options: short October 2019 $37 calls on eBay and long January 2021 $18 calls on eBay.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »